Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079602 | SCV000111484 | benign | not specified | 2013-04-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000079602 | SCV000170906 | benign | not specified | 2012-03-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000079602 | SCV000194418 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000227839 | SCV000286298 | benign | Developmental and epileptic encephalopathy, 9 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079602 | SCV000306975 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002313761 | SCV000847918 | benign | Inborn genetic diseases | 2016-06-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000227839 | SCV002812032 | likely benign | Developmental and epileptic encephalopathy, 9 | 2021-10-20 | criteria provided, single submitter | clinical testing |